Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples High-Excitability rats

Behavioural Brain Research

Volumn 210, Issue 1, 2010, Pages 99-106

  Ruocco, L A ^a   Gironi Carnevale, U A ^a   Treno, C ^a   Sadile, A G ^a   Melisi, D ^c   Arra, C ^d   Ibba, M ^b   Schirru, C ^b   Carboni, E ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c U of Naples   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Atomoxetine; Dopamine; Methylphenidate; Naples High Excitability rats; Norepinephrine; Serotonin

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; ATOMOXETINE; HOMOVANILLIC ACID; METHYLPHENIDATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; LEARNING; MALE; MAZE TEST; MESENCEPHALON; MOTOR CORTEX; NONHUMAN; NORADRENALIN BRAIN LEVEL; PREFRONTAL CORTEX; PREPUBERTY; PRIORITY JOURNAL; PROGNOSIS; RAT; SELECTIVE ATTENTION; SEROTONIN BRAIN LEVEL;

ADRENERGIC UPTAKE INHIBITORS; AGING; ANIMALS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; DOPAMINE; MALE; MAZE LEARNING; METHYLPHENIDATE; NOREPINEPHRINE; PROPYLAMINES; PROSENCEPHALON; RANDOM ALLOCATION; RATS; SEROTONIN; TIME FACTORS;

EID: 77949566636     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.02.020     Document Type: Article

References (46)

1. Arnsten A.F. Catecholamine regulation of the prefrontal cortex. J Psychopharmacol 1997, 11:151-162.
2. Arnsten A.F., Li B.M. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 2005, 57:1377-1384.
3. Bari A., Eagle D.M., Mar A.C., Robinson E.S., Robbins T.W. Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats. Psychopharmacology (Berl) 2009, 205:273-283.
4. Bolanos C.A., Willey M.D., Maffeo M.L., Powers K.D., Kinka D.W., Grausam K.B., et al. Antidepressant treatment can normalize adult behavioral deficits induced by early-life exposure to methylphenidate. Biol Psychiatry 2008, 63:309-316.
5. Broadhurst P.L. Experiments in psychogenetics: application of biometrical genetics to the inheritance of behavior. Experiments in personality, vol. I. Psychogenetics and psychopharmacology 1960, 1-102. Routledge, Regan Paul, London. H.J. Eysenck (Ed.).
6. Bymaster F.P., Katner J.S., Nelson D.L., Hemrick-Luecke S.K., Threlkeld P.G., Heiligenstein J.H., et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 2002, 27:699-711.
7. Carboni E., Silvagni A. Experimental investigations on dopamine transmission can provide clues on the therapeutic effect of amphetamine and methylphenidate in ADHD. Neural Plasticity 2004, 11:77-95.
8. Carr D.B., O'Donnell P., Card J.P., Sesack S.R. Dopamine terminals in the rat prefontal cortex synapse on pyramidal cells that project to the nucleus accumbens. J Neurosci 1999, 19:11049-11060.
9. Castellanos F.X., Lee P.P., Sharp W., Jeffries N.O., Greenstein D.K., Clasen L.S., et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 2002, 288:1740-1748.
10. Cerbone A., Sadile A.G. Behavioral habituation to spatial novelty: interference and noninterference studies. Neurosci Biobehav Rev 1994, 18(4):497-518.
11. Chavez B., Sopko M.A., Ehret M.J., Paulino R.E., Goldberg K.R., Angstadt K., et al. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder. Ann Pharmacother 2009, 43:1084-1095.
12. Dahl R.E. Adolescent development and the regulation of behavior and emotion: introduction to part VIII. Ann N Y Acad Sci 2004, 1021:294-295.
13. Davids E., Zhang K., Tarazi F.I., Baldessarini R.J. Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev 2003, 42:1-21.
14. Dommett E.J., Henderson E.L., Westwell M.S., Greenfield S.A. Methylphenidate amplifies long-term plasticity in the hippocampus via noradrenergic mechanisms. Learn Mem 2008, 15:580-586.
15. Fuster J.M. Executive frontal functions. Exp Brain Res 2000, 133:66-70.
16. Garnock-Jones K.P., Keating G.M. Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents. Paediatr Drugs 2009, 11:203-226.
17. Giedd J.N., Blumenthal J., Jeffries N.O., Castellanos F.X., Liu H., Zijdenbos A., et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci 1999, 2:861-863.
18. Gironi Carnevale U.A., Vitullo E., Varriale B., Ruocco L.A., Sadile A.G. A classical Mendelian cross-breeding study of the Naples high and low excitability rat lines. Behav Brain Res 2007, 183:130-140.
19. Goldman-Rakic P.S. Regional and cellular fractionation of working memory. Proc Natl Acad Sci USA 1996, 93:13473-13480.
20. Grace A.A., Bunnney B.S., Moore H., Todd C.L. Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs. Trends Neurosci 1997, 20:31-37.
21. Heal D.J., Smith S.L., Kulkarni R.S., Rowley H.L. New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD. Pharmacol Biochem Behav 2008, 90:184-197.
22. Hölm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979, 6:65-70.
23. Jacobs B.L., Fornal C.A. Serotonin and motor activity. Curr Opin Neurobiol 1997, 7:820-825.
24. Kolomiets B.P., Deniau J.M., Glowinski J., Thierry A.M. Basal ganglia and processing of cortical information: functional interactions between trans-striatal and trans-subthalamic circuits in the substantia nigra pars reticulata. Neuroscience 2003, 117:931-938.
25. Kuczenski R., Segal D.S. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J Pharmacol Exp Ther 2001, 296:876-883.
26. Leranth C., Hajszan T. Extrinsic afferent systems to the dentate gyrus. Prog Brain Res 2007, 163:63-84.
27. Mejias-Aponte C.A., Drouin C., Aston-Jones G. Adrenergic and noradrenergic innervation of the midbrain ventral tegmental area and retrorubral field: prominent inputs from medullary homeostatic centers. J Neurosci 2009, 29:3613-3626.
28. Newman L.A., Darling J., McGaughy J. Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex. Psychopharmacology (Berl) 2008, 200:39-50.
29. O'Leary O.F., Bechtholt A.J., Crowley J.J., Valentino R.J., Lucki I. The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs. Eur Neuropsychopharmacol 2007, 17:215-226.
30. Oades R.D. Role of the serotonin system in ADHD: treatment implications. Expert Rev Neurother 2007, 7:1357-1374.
31. Pattij T., Vanderschuren L.J. The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci 2008, 29:192-199.
32. Paus T., Zijdenbos A., Worsley K., Collins D.L., Blumenthal J., Giedd J.N., et al. Structural maturation of neural pathways in children and adolescents: in vivo study. Science 1999, 283:1908-1911.
33. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, Academic Press, London.
34. Pliszka S.R., McCracken J.T., Maas J.W. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry 1996, 35:264-272.
35. Prince J. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update. J Clin Psychopharmacol 2008, 28:S39-S45.
36. Ruocco L.A., de Souza Silva M.A., Topic B., Mattern C., Huston J.P., Sadile A.G. Intranasal application of dopamine reduces activity and improves attention in Naples high excitability rats that feature the mesocortical variant of ADHD. Euro Neuropsycopharmacol 2009, 19:693-701.
37. Ruocco L.A., Gironi Carnevale U.A., Sica A., Arra C., Topo E., Di Maio A., et al. Differential prepuberal handling modifies behaviour and excitatory amino acids in the forebrain of the naples high-excitability rats. Behav Brain Res 2009, 198:29-36.
38. Ruocco L.A., Sadile A.G., Gironi Carnevale U.A. Modeling the mesocortical variant of ADHD: the Naples high excitability rats. Attention deficit hyperactivity disorder 2009, 85-106. Nova Science, New York. S.M. Gordon, A.M. Mitchell (Eds.).
39. Ruocco L.A., Viggiano D., Viggiano A., Abignente E., Rimoli M.G., Melisi D., et al. Galactosilated dopamine enters into the brain, blocks mesocorticolimbic system and modulates activity and scanning time in Naples High Excitability Rats. Neuroscience 2008, 152:234-244.
40. Sagvolden T., Russell V.A., Aase H., Johansen E.B., Farshbaf M. Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1239-1247.
41. Sonuga-Barke E.J., Sergeant J.A., Nigg J., Willcutt E. Executive dysfunction and delay aversion in attention deficit hyperactivity disorder: nosologic and diagnostic implications. Child Adolesc Psychiatr Clin N Am 2008, 17. 367-84, ix.
42. Viggiano D., Ruocco L.A., Pignatelli M., Grammatikopoulos G., Sadile A.G. Prenatal elevation of endocannabinois corrects the unbalance between dopamine systems and reduces activity in the Naples High Excitability rats. Neurosci Biobehav Rev 2003, 27:129-139.
43. Viggiano D., Vallone D., Welzl H., Sadile A.G. The Naples high-and low excitability rats: selective breeding, behavioral profile, morphometry and molecular biology of the mesocortical dopamine system. Behav Genet 2002, 32:315-333.
44. Volkow N.D., Gatley J.S., Fowler J.S., Wang G.J., Swanson J. Serotonin and the therapeutic effects of ritalin. Science 2000, 288:11.
45. Whishaw I.Q., Vanderwolf C.H. Hippocampal EEG and behavior: changes in amplitude and frequency of RSA (theta rhythm) associated with spontaneous and learned movement patterns in rats and cats. Behav Biol 1973, 8:461-484.
46. Yano M., Steiner H. Methylphenidate and cocaine: the same effects on gene regulation?. Trends Pharmacol Sci 2007, 28:588-596.